Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Albers-Schoenberg Disease

vidarabine has been researched along with Albers-Schoenberg Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avni, B; Grisariu, S; Hussein, F; Lokshin, E; NaserEddin, A; Oron, HC; Shadur, B; Stepensky, P; Zaidman, I1
Drozdinsky, G; Erlich, O; Gorelik, N; Lamdan, R; Natsheh, J; Or, R; Simanovsky, N; Stepensky, P; Weintraub, M1

Other Studies

2 other study(ies) available for vidarabine and Albers-Schoenberg Disease

ArticleYear
Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Melphalan; Myeloablative Agonists; Osteopetrosis; Prognosis; Retrospective Studies; Transplantation Conditioning; Vidarabine; Young Adult

2018
Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:3

    Topics: Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hypercalcemia; Infant; Infant, Newborn; Male; Osteopetrosis; Postoperative Complications; Tissue Donors; Tissue Survival; Transplantation Conditioning; Treatment Outcome; Vidarabine

2016